Teresa Foy
Director/Board Member at NANOSTRING TECHNOLOGIES, INC.
Net worth: 14 164 $ as of 2024-04-29
Teresa Foy active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Director/Board Member | 2022-04-17 | - |
| Independent Dir/Board Member | 2022-04-17 | - | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2019-10-31 | - |
Career history of Teresa Foy
Former positions of Teresa Foy
| Companies | Position | Start | End |
|---|---|---|---|
Oncofactor Corp.
 Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Oncofactor Corp. develops antibody drugs against new biologic targets in cancer. Its cancer therapeutics that disrupt signaling pathways between tumors and the immune system. The company was founded by Sarah Ellen Warren in 2011 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | - | - |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Corporate Officer/Principal | - | - |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - | - |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 2010-01-26 | - |
| Corporate Officer/Principal | - | 2010-01-26 |
Training of Teresa Foy
| University of Minnesota | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
| St. Cloud State University | Graduate Degree |
Statistics
International
| United States | 9 |
| Belgium | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 4 |
|---|---|
Viral Logic Systems Technology Corp.
Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Health Technology |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Oncofactor Corp.
Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Oncofactor Corp. develops antibody drugs against new biologic targets in cancer. Its cancer therapeutics that disrupt signaling pathways between tumors and the immune system. The company was founded by Sarah Ellen Warren in 2011 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Teresa Foy
- Experience
